23andMe was founded in 2006 as a direct-to-consumer genetics testing specialist and became a publicly traded company in June 2021, trading under the ticker symbol “ME.” At the time, co-founder and CEO Anne Wojcicki said the company had over 11 million users that were using genetics to transform how they…
